SUMMARY Three cases of Japanese patients with gyrate atrophy of the choroid and retina with hyperornithinaemia were studied clinically and biochemically. The types of disease differed in responsiveness to vitamin B6. In-vivo responsiveness to vitamin B6 was correlated with in-vitro data. It is suggested that the in-vitro examination of the influence of pyridoxal phosphate on omithine ketoacid transaminase activity in cultured fibroblasts may be useful in ascertaining the efficacy of vitamin B6 treatment in gyrate atrophy. In addition the early development of the fundus lesions was observed in one case (case 1), and the ciliary body abnormality and chorioretinal atrophy were noted in another (case 3).
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Large doses of vitamin B6 have been tried in the treatment of gyrate atrophy of choroid and retina since Simell and Takki' found hyperornithinaemia in these cases and several investigators2 confirmed deficient activity of omithine ketoacid aminotransferase in cultured fibroblasts or lymphocytes from the affected patients. Genetic heterogeneity of the disease in responsiveness to vitamin B6 was suggested recently.367 But a study of both in-vivo and in-vitro responsiveness to vitamin B6 has been lacking. We therefore investigated whether in-vivo responsiveness to vitamin B6 is correlated with in-vitro data.
Case reports
Three patients with gyrate atrophy with hyperornithinaemia, their parents and a sister, and normal controls were examined in this study. Case 1. A 5-year-old boy was first seen at the Departments of Paediatrics and Ophthalmology of Tohoku University Hospital at the age of 2 years, because his mother noticed he had thick speech and brown hair. Delivery and development were normal. The boy was the second son of a consanguineous marriage. On examination he appeared normal, except for hyperornithinaemia (8- examination showed no abnormal lesion in the ocular fundi at the ages of 2 and 3 years. Yellow-white spots at the peripheral fundus ( Fig. 1) and an abnormal reflex in the macular area were first noted at the age of 4 years. The visual acuity of both eyes was 0-3 with correction of myopia (-2 D). The optical media were clear. He complained of night blindness at the age of5 years. The electroretinogram was subnormal. The ciliary processes were normal by cycloscopy. The clinical diagnosis of early gyrate atrophy was made.
Case 2. An 8-year-old boy first noted decreased Ophthalmoscopically chorioretinal atrophy with the characteristic scalloped border approached the posterior pole (Fig. 3) . Cycloscopically short and scanty ciliary processes were noted (Fig. 4) . The Hyperomithinaemia (6-92 mg/dl (69-2 mg/I)) was noted ( Table 1 ). The clinical diagnosis of typical gyrate atrophy was made.
Parents and a sister. The parents and a sister of these patients had good visual acuity and no abnormal atrophic lesions in the ocular fundi. Serum amino acids were within normal limits.
Materials and methods
Serum amino acids were measured on a Hitachi amino acid analyser (type 835). Skin biopsy material was cut into small fragments and cultured in Eagle's medium (MEM) supplemented with 10% fetal calf serum and nonessential amino acids. When the monolayers had grown to confluency, they were trypsinised and the fibroblasts were harvested for enzyme analysis. Cell lysates were prepared by twice freezing and thawing and further sonication at 60 kilocycles for 10 s of the washed cells in saline. For one enzyme assay a cell lysate obtained from 1 to 2 x 106 cells was required.
Cell extracts of phytohaemagglutinin-transformed lymphocytes were prepared by the method ofBerger.8 Briefly, the peripheral blood lymphocytes prepared from heparinised blood were cultured for 72 hours in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% fetal calf serum and phytohaemagglutinin (5 ,ug per ml). Cells harvested were sonicated at 60 kilocycles for 10 s for enzyme assay.
Ornithine ketoacid aminotransferase activity was determined by spectrophotometric and radioisotopic methods. Spectrophotometric assay is a modification of the method of Katsunuma and coworkers.9 Briefly, the reaction mixture usually contained 4 ,umol ornithine, 1 ,umol a-ketoglutarate, 40 nmol pyridoxal phosphate, and enzyme source (cell lysate) at pH 8-0 in a total volume of 0-4 ml. Incubation was carried out at 37°C for 30 min. The amount of pyrroline-5-carboxylate formed was determined spectrophotometrically. Although heterogeneity of gyrate atrophy in vitamin B6 response has been previously reported,367 the relationship between in-vitro and in-vivo responsiveness has not been noted. Shih and coworkers3 reported only the in-vitro data of the effect of pyridoxal phosphate, while Kaiser-Kupfer and coworkers7 showed only the in-vivo reduction of plasma omithine level in response to oral vitamin B6. The value of the enzyme activity was not described in the preliminary report of Welber et al. 6 The present study confirms the correlation of in-vivo and in-vitro responsiveness of gyrate atrophy to vitamin B6 and the presence of different types. It also strongly suggests that the in-vitro examination of the influence of pyridoxal phosphate on enzyme activity in the cultured fibroblasts may help us to determine the efficacy of vitamin B6 treatment in gyrate atrophy.
Case 1 had a normal appearance of the ocular fundi at the ages of 2 and 3 years. The yellowish white atrophic patches began at the age of 4 years. This is in agreement with the observation'4 1 that ocular lesions begin at around the age of 4 years.
Cyloscopic observation is also interesting. We previously'6 reported the high enzyme activity of ornithine ketoacid transaminase in the bovine retinal pigment epithelium, ciliary body, and iris. A cyclogram of case 3 (Fig. 4) shows the short and scanty ciliary processes. Cycloscopically, the ciliary processes in the affected children (cases 1 and 2) were normal, while those in the young adult patient (case 3) were short and scanty. Another young adult (21 years old) with gyrate atrophy showed similar lesions of the ciliary body (unpublished observation). The data suggested involvement of the ciliary body with age as well as retinochoroidal atrophy in the gyrate atrophy.
